Psoriasin interacts with Jab1 and influences breast cancer progression

Cancer Research

Volumn 63, Issue 8, 2003, Pages 1954-1961

  Emberley, Ethan D ^a   Niu, Yulian ^a   Leygue, Etienne ^a   Tomes, Ladislav ^a   Gietz, R Daniel ^a   Murphy, Leigh C ^a   Watson, Peter H ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C JUN ACTIVATION DOMAIN BINDING PROTEIN 1; CHEMOTACTIC FACTOR; PROTEIN; PROTEIN HIF1; PROTEIN P27; PSORIASIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER GROWTH; CARCINOGENICITY; CARCINOMA IN SITU; CELL ADHESION; CELL FUNCTION; CELL INVASION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; DISEASE PROGRESSION; DNA-BINDING PROTEINS; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; PEPTIDE HYDROLASES; SUBCELLULAR FRACTIONS; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0037447205     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Leygue, E., Snell, L., Hiller, T., Dotzlaw, H., Hole, K., Murphy, L. C., and Watson, P. H. Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res., 56: 4606-4609, 1996.
2. Enerback, C., Porter, D. A., Seth, P., Sgroi, D., Gaudet, J., Weremowicz, S., Morton, C. C., Schnitt, S., Pitts, R. L., Stampl, J., Barnhart, K., and Polyak, K. Psoriasin expression in mammary epithelial cells in vitro and in vivo. Cancer Res., 62: 43-47, 2002.
3. Porter, D. A., Krop, I. E., Nasser, S., Sgroi, D., Kaelin, C. M., Marks, J. R., Riggins, G., and Polyak, K. A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res., 61: 5697-5702, 2001.
4. Al Haddad, S., Zhang, Z., Leygue, E., Snell, L., Huang, A., Niu, Y., Hiller-Hitchcock, T., Hole, K., Murphy, L. C., and Watson, P. H. Psoriasin (S100A7) expression and invasive breast cancer. Am. J. Pathol., 155: 2057-2066. 1999.
5. Watson, P. H., Leygue, E. R., and Murphy, L. C. Psoriasin (S 100A7). Int. J. Biochem. Cell Biol., 30: 567-571, 1998.
6. Ridinger, K., Ilg, E. C., Niggli, F. K., Heizmann, C. W., and Schafer, B. W. Clustered organization of S100 genes in human and mouse. Biochim. Biophys. Acta, 1448: 254-263, 1998.
7. Borglum, A. D., Flint, T., Madsen, P., Celis, J. E., and Kruse, T. A. Refined mapping of the psoriasin gene S100A7 to chromosome 1cen-q21. Hum. Genet., 96: 592-596, 1995.
8. Pedrocchi, M., Schafer, B. W., Mueller, H., Eppenberger, U., and Heizmann, C. W. Expression of Ca(2+)-binding proteins of the S100 family in malignant human breast-cancer cell lines and biopsy samples. Int. J. Cancer, 57: 684-690, 1994.
9. Ilg, E. C., Schafer, B. W., and Heizmann, C. W. Expression pattern of S100 calcium-binding proteins in human tumors. Int. J. Cancer. 68: 325-332, 1996.
10. Mazzucchelli, L. Protein S100A4: too long overlooked by pathologists? Am. J. Pathol., 160: 7-13, 2002.
11. Barraclough, R., and Rudland, P. S. The S-100-related calcium-binding protein, p9Ka, and metastasis in rodent and human mammary cells. Eur. J. Cancer, 30A: 1570-1576, 1994.
12. Ford, H. L., Salim, M. M., Chakravarty, R., Aluiddin, V., and Zain, S. B. Expression of Mts1, a metastasis-associated gene, increases motility but not invasion of a nonmetastatic mouse mammary adenocarcinoma cell line. Oncogene, 11: 2067-2075, 1995.
13. Grigorian, M., Ambartsumian, N., Lykkesfeldt, A. E., Bastholm, L., Elling, F., Georgiev, G., and Lukanidin, E. Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int. J. Cancer, 67: 831-841, 1996.
14. Lloyd, B. H., Platt-Higgins, A., Rudland, P. S., and Barraclough, R. Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells. Oncogene, 17: 465-473, 1998.
15. Davies, M. P., Rudland, P. S., Robertson, L., Parry, E. W., Jolicoeur, P., and Barraclough, R. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene, 13: 1631-1637, 1996.
16. Rudland, P. S., Platt-Higgins, A., Renshaw, C., West, C. R., Winstanley, J. H., Robertson, L., and Barraclough, R. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res., 60: 1595-1603, 2000.
17. Madsen, P., Rasmussen, H. H., Leffers, H., Honore, B., Dejgaard, K., Olsen, E., Kiil, J., Walbum, E., Andersen, A. H., Basse, B., Laurisden, J. B., Ratz, G. P., Celis, A., VandeKerckhove, J., and Celis, J. E. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J. Investig. Dermatol., 97: 701-712, 1991.
18. Jinquan, T., Vorum, H., Larsen, C. G., Madsen, P., Rasmussen, H. H., Gesser, B., Etzerodt, M., Honore, B., Celis, J. E., and Thestrup-Pedersen, K. Psoriasin: a novel chemotactic protein. J. Investig. Dermatol., 107: 5-10, 1996.
19. Hagens, G., Roulin, K., Hotz, R., Saurat, J. H., Hellman, U., and Siegenthaler, G. Probable interaction between S100A7 and E-FABP in the cytosol of human keratinocytes from psoriatic scales. Mol. Cell Biochem., 192: 123-128, 1999.
20. Fields, S., and Song, O. A novel genetic system to detect protein-protein interactions. Nature (Lond.), 340: 245-246, 1989.
21. Claret, F. X., Hibi, M., Dhut, S., Toda, T., and Karin, M. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature (Lond.), 383: 453-457, 1996.
22. Kwok, S. F., Solano, R., Tsuge, T., Chamovitz, D. A., Ecker, J. R., Matsui, M., and Deng, X. W. Arabidopsis homologs of a c-Jun coactivator are present both in monomeric form and in the COP9 complex, and their abundance is differentially affected by the pleiotropic cop/det/fus mutations. Plant Cell, 10: 1779-1790, 1998.
23. Seeger, M., Kraft, R., Ferrell, K., Bech-Otschir, D., Dumdey, R., Schade, R., Gordon, C., Naumann, M., and Dubiel, W. A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J., 12: 469-478, 1998.
24. Chamovitz, D. A., and Glickman, M. The COP9 signalosome. Curr. Biol., 12: R232, 2002.
25. Schwechheimer, C., and Deng, X. W. COP9 signalosome revisited: a novel mediator of protein degradation. Trends Cell Biol., 11: 420-426, 2001.
26. Gietz, R. D., Triggs-Raine, B., Robbins, A., Graham, K. C., and Woods, R. A. Identification of proteins that interact with a protein of interest: applications of the yeast two-hybrid system. Mol. Cell Biochem., 172: 67-79, 1997.
27. Wykoff, C. C., Beasley, N. J., Watson, P. H., Turner, K. J., Pastorek, J., Sibtain, A., Wilson, G. D., Turley, H., Talks, K. L., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., and Harris, A. L. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res., 60: 7075-7083, 2000.
28. Kleemann, R., Hausser, A., Geiger, G., Mischke. R., Burger-Kentischer, A., Flieger, O., Johannes, F. J., Roger, T., Calandra, T., Kapurniotu, A., Grell, M., Finkelmeier, D., Brunner, H., and Bernhagen, J. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature (Lond.), 408: 211-216, 2000.
29. Tomoda, K., Kubota, Y., Arata, Y., Mori, S., Maeda, M., Tanaka, T., Yoshida, M., Yoneda-Kato, N., and Kato, J. Y. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J. Biol. Chem., 277: 2302-2310, 2002.
30. Kolch, W., Martiny-Baron, G., Kieser, A., and Marine, D. Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res. Treat., 36: 139-155, 1995.
31. Selvamurugan, N., and Partridge, N. C. Constitutive expression and regulation of collagenase-3 in human breast cancer cells. Mol. Cell Biol. Res. Commun., 3: 218-223, 2000.
32. Bae, M. K., Ahn, M. Y., Jeong, J. W., Bae, M. H., Lee, Y. M., Bae, S. K., Park, J. W., Kim, K. R., and Kim, K. W. Jab1 interacts directly with HIF-1α and regulates its stability. J. Biol. Chem., 277: 9-12, 2002.
33. Kaluzova, M., Pastorekova, S., Svastova, E., Pastorek, J., Stanbridge, E. J., and Kaluz, S. Characterization of the MN/CA 9 promoter proximal region: a role for specificity protein (SP) and activator protein 1 (AP1) factors. Biochem. J., 359: 669-677, 2001.
34. Laderoute, K. R., Calaoagan, J. M., Gustafson-Brown, C., Knapp, A. M., Li, G. C., Mendonca, H. L., Ryan, H. E., Wang, Z., and Johnson, R. S. The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 α dependent. Mol. Cell Biol., 22: 2515-2523, 2002.
35. Michiels, C., Minet, E., Michel, G., Mottet, D., Piret, J. P., and Raes, M. HIF-1 and AP-1 cooperate to increase gene expression in hypoxia: role of MAP kinases. IUBMB. Life, 52: 49-53, 2001.
36. Polyak, K. Molecular alterations in ductal carcinoma in situ of the breast. Curr. Opin. Oncol., 14: 92-96, 2002.
37. Stetler-Stevenson, W. G., and Yu, A. E. Proteases in invasion: matrix metalloproteinases. Semin. Cancer Biol., 11: 143-152, 2001.
38. Bianchi, E., Denti, S., Granata, A., Bossi, G., Geginat, J., Villa, A., Rogge, L., and Pardi, R. Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity. Nature (Lond.), 404: 617-621. 2000.
39. Chauchereau, A., Georgiakaki, M., Perrin-Wolff, M., Milgrom, E., and Loosfelt, H. JAB1 interacts with both the progesterone receptor and SRC-1. J. Biol. Chem., 275: 8540-8548, 2000.
40. Naumann, M., Bech-Otschir, D., Huang, X., Ferrell, K., and Dubiel, W. COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK. J. Biol. Chem., 274: 35297-35300, 1999.
41. Wan, M., Cao, X., Wu, Y., Bai, S., Wu, L., Shi, X., Wang, N., and Cao, X. Jab1 antagonizes TGF-β signaling by inducing Smad4 degradation. EMBO Rep., 3: 171-176, 2002.
42. Bech-Otschir, D., Kraft, R., Huang, X., Henklein, P., Kapelari, B., Pollmann, C., and Dubiel, W. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J., 20: 1630-1639, 2001.
43. Tomoda, K., Kubota, Y., and Kato, J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature (Lond.), 398: 160-165, 1999.
44. Sui, L., Dong, Y., Ohno, M., Watanabe, Y., Sugimoto, K., Tai, Y., and Tokuda, M. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. Clin. Cancer Res., 7: 4130-4135, 2001.
45. Gemmill, R. M., Bemis, L. T., Lee, J. P., Sozen, M. A., Baron, A., Zeng, C., Erickson, P. F., Hooper, J. E., and Drabkin, H. A. The TRC8 hereditary kidney cancer gene suppresses growth and functions with VHL in a common pathway. Oncogene, 21: 3507-3516, 2002.
46. Done, S. J., Arneson, C. R., Ozcelik, H., Redston, M., and Andrulis, I. L. P53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers. Breast Cancer Res. Treat., 65: 111-118. 2001.
47. Kang, J. H., Kim, S, J., Noh, D. Y., Choe, K. J., Lee, E. S., and Kang, H. S. The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer. J. Mol. Med., 79: 648-655, 2001.
48. Lagios, M. D. Classification of duct carcinoma in situ (DCIS) with a characterization of high grade lesions: defining cohorts for chemoprevention trials. J. Cell Biochem., 25(Suppl.): 108-111, 1996.
49. Ringberg, A., Anagnostai, L., Anderson, H., Idvall, I., and Ferno, M. Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics. Eur. J. Cancer. 37: 1514-1522, 2001.
50. Pouliot, F., and Labrie, C. Expression profile of agonistic Smads in human breast cancer cells: absence of regulation by estrogens. Int. J. Cancer. 81: 98-103, 1999.
51. Shaulian, E., and Karin, M. AP-1 in cell proliferation and survival. Oncogene, 20: 2390-2400, 2001.
52. Ozanne, B. W., McGarry, L., Spence, H. J., Johnston, I., Winnie, J., Meagher, L., and Stapleton, G. Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme. Eur. J. Cancer, 36: 1640-1648, 2000.
53. Smith, L. M., Wise, S. C., Hendricks, D. T., Sabichi, A. L., Bos, T., Reddy, P., Brown, P. H., and Birrer, M. J. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene, 18: 6063-6070, 1999.
54. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86: 353-364, 1996.
55. Karpanen, T., Egeblad, M., Karkkainen, M. J., Kubo, H., Yla-Herttuala, S., Jaattela, M., and Alitalo, K. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res., 61: 1786-1790, 2001.
56. Chamovitz, D. A., and Segal, D. JAB1/CSN5 and the COP9 signalosome. A complex situation. EMBO Rep., 2: 96-101, 2001.
57. Pollmann, C., Huang, X., Mall, J., Bech-Otschir, D., Naumann, M., and Dubiel, W. The constitutive photomorphogenesis 9 signalosome directs vascular endothelial growth factor production in tumor cells. Cancer Res., 61: 8416-8421, 2001.
58. Donato, R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol., 33: 637-668, 2001.
59. Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., Neurath, M. F., Slattery, T., Beach, D., McClary, J., Nagashima, M., Morser, J., Stem, D., and Schmidt, A. M. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell, 97: 889-901, 1999.
60. Schmidt, A. M., Yan, S. D., Yan, S. F., and Stern, D. M. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta. 1498: 99-111, 2000.
61. Kuniyasu, H., Oue, N., Wakikawa, A., Shigeishi, H., Matsutani, N., Kuraoka, K., Ito, R., Yokozaki, H., and Yasui, W. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J. Pathol., 196: 163-170, 2002.
62. Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., Hofmann, M. A., Kislinger, T., Ingram, M., Lu, A., Tanaka, H., Hori, O., Ogawa, S., Stern, D. M., and Schmidt, A. M. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature (Lond.), 405: 354-360, 2000.
63. Robinson, M. J., and Hogg, N. A comparison of human S100A12 with MRP-14 (S100A9). Biochem. Biophys. Res. Commun., 275: 865-870, 2000.